Sandoz shipped pantoprazole sodium, an injectable drug used to treat adults with astroesophageal reflux disease as well as pathological hypersecretion conditions, including Zollinger-Ellison syndrome.
Sandoz and Civica Rx entered into a five-year agreement in July for Sandoz to supply it with drugs that are commonly in shortage in U.S. hospitals. Civica Rx is a nonprofit organization fighting drug shortages.
Sandoz had said it plans to supply six injectable drugs to Civica Rx, but announced Nov. 2 that it will add a drug used to regulate blood pressure, which has been frequently used to treat COVID-19 patients.
Read the full news release here.
More articles on pharmacy:
FDA reviewers appear to endorse Biogen’s Alzheimer’s drug
Americans have almost doubled spending on specialty drugs from pharmacies, study finds
FDA, FTC warn 2 companies selling faulty COVID-19 treatments
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.